Scandion Oncology A/S/News/BioStock Studio: Scandion Oncology pushes forward with confidence

BioStock Studio: Scandion Oncology pushes forward with confidence

29 June 2020 - 08:21

Scandion Oncology has been very active of late, which has had significant effect on the company share. BioStock was happy to welcome CEO Nils Brünner back to the BioStock studio to give us some background about the company and discuss what makes Scandion Oncology an attractive investment.

Watch the video interview with Scandion Oncology's CEO Nils Brünner at biostock.se:

https://www.biostock.se/en/biostock-studio-scandion-oncology-pushes-forward-with-confidence/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Provided by: Cision

Scandion Oncology A/S

Scandion is a biotechnology company. The company develops pharmaceuticals for the treatment of cancer containing drug-resistant cell clones. The leading product of the company, SCO-101, has shown to improve the effect of certain standard cancer treatments during preclinical studies. The head office of the company is located in Copenhagen....

Learn more about company

Related news

19.01.2021

NEOVACS

NEOVACS : LEVÉE DE FONDS DE 2,85 MEUR ET FIN DU PROGRAMME D'ORNANE

Paris et Boston, le 19 janvier 2021 – 18h CET - Néovacs (Euronext Growth Paris : ALNEV) annonce une levée de fonds de 2,85 M€ par le tirage de 1 tranche d'OCEANE-BSA, d'une valeur nominale de 1000000€, souscrite par European High Growth Opportu...

19.01.2021

Scandion Oncology A/S

Scandion Oncology approved for listing on Nasdaq First North Growth Market Sweden on 3 February 2021

Scandion has applied for and received approval for admission to trading on Nasdaq First North. The first day of trading in the Company’s share on Nasdaq First North is 3 February 2021. Trading in the Company’s share on Spotlight Stock Market will end and the last day of trading on Spotlight Stock Ma...

19.01.2021

Iconovo AB

Kommande presentationer av Iconovo

Aktiespararna – Aktiedagen LundPresentation Iconovo Onsdag 27 januari kl. 10.15-10.45Datum: 27 och 28 januari 2021Tid: 08.00-21.00Plats: Digital, livestreaming via webbAnmälningar via Hemsida/website: https://www.aktiespararna.se/aktiviteter/aktiedagen-lund-digitaltVi streamar live och on demand via...

19.01.2021

AlzeCure Pharma AB

AlzeCure presenterar på Aktiedagen Lund den 27 januari

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), ett läkemedelsbolag som utvecklar en bred portfölj av produktkandidater för sjukdomar som drabbar det centrala nervsystemet, med projekt inom både Alzheimers sjukdom och smärta, meddelar idag att bolaget medverkar på Aktiespararnas Aktiedagen Lund den 27 j...